166 related articles for article (PubMed ID: 7782118)
1. Monitoring exposure of hospital personnel handling cytostatic drugs and contaminated materials.
DeMéo MP; Mérono S; DeBaille AD; Botta A; Laget M; Guiraud H; Duménil G
Int Arch Occup Environ Health; 1995; 66(6):363-8. PubMed ID: 7782118
[TBL] [Abstract][Full Text] [Related]
2. Handling of cytostatic drugs and urine mutagenesis.
Poyen D; De Méo MP; Botta A; Gouvernet J; Duménil G
Int Arch Occup Environ Health; 1988; 61(3):183-8. PubMed ID: 3220590
[TBL] [Abstract][Full Text] [Related]
3. Mutagenicity in urine from nurses handling cytostatic agents.
Benhamou S; Callais F; Sancho-Garnier H; Min S; Courtois YA; Festy B
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1489-93. PubMed ID: 3595674
[TBL] [Abstract][Full Text] [Related]
4. Mutagenicity of urine from nurses handling cytostatic drugs, influence of smoking.
Bos RP; Leenaars AO; Theuws JL; Henderson PT
Int Arch Occup Environ Health; 1982; 50(4):359-69. PubMed ID: 6757139
[TBL] [Abstract][Full Text] [Related]
5. Limitations of the salmonella/mammalian microsome assay (Ames test) to determine occupational exposure to cytostatic drugs.
Friederich U; Molko F; Hofmann V; Scossa D; Hann D; Würgler FE; Senn HJ
Eur J Cancer Clin Oncol; 1986 May; 22(5):567-75. PubMed ID: 3533554
[TBL] [Abstract][Full Text] [Related]
6. Urine mutagenicity in workers directly employed in coke production.
Mielzyńska D; Snit M
Pol J Occup Med Environ Health; 1992; 5(4):363-71. PubMed ID: 1298485
[TBL] [Abstract][Full Text] [Related]
7. Comparison of methods for the biomonitoring of nurses handling antitumor drugs.
Thiringer G; Granung G; Holmén A; Högstedt B; Järvholm B; Jönsson D; Persson L; Wahlström J; Westin J
Scand J Work Environ Health; 1991 Apr; 17(2):133-8. PubMed ID: 2047815
[TBL] [Abstract][Full Text] [Related]
8. Limitations of urinary mutagen assays for monitoring occupational exposure to antineoplastic drugs.
Tuffnell PG; Gannon MT; Dong A; DeBoer G; Erlichman C
Am J Hosp Pharm; 1986 Feb; 43(2):344-8. PubMed ID: 3513557
[TBL] [Abstract][Full Text] [Related]
9. Detection of low levels of urinary mutagen excretion by chemotherapy workers which was not related to occupational drug exposures.
Everson RB; Ratcliffe JM; Flack PM; Hoffman DM; Watanabe AS
Cancer Res; 1985 Dec; 45(12 Pt 1):6487-97. PubMed ID: 4063994
[TBL] [Abstract][Full Text] [Related]
10. Urinary 1-hydroxypyrene and mutagenicity in bus drivers and mail carriers exposed to urban air pollution in Denmark.
Hansen AM; Wallin H; Binderup ML; Dybdahl M; Autrup H; Loft S; Knudsen LE
Mutat Res; 2004 Jan; 557(1):7-17. PubMed ID: 14706514
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a battery of Salmonella typhimurium tester strains for biomonitoring of mutagenic polycyclic aromatic hydrocarbons, nitroarenes and aromatic amines.
Nikoyan A; De Méo M; Sari-Minodier I; Chaspoul F; Gallice P; Botta A
Mutat Res; 2007 Jan; 626(1-2):88-101. PubMed ID: 17095286
[TBL] [Abstract][Full Text] [Related]
12. Stability and inactivation of mutagenic drugs and their metabolites in the urine of patients administered antineoplastic therapy.
Monteith DK; Connor TH; Benvenuto JA; Fairchild EJ; Theiss JC
Environ Mol Mutagen; 1987; 10(4):341-56. PubMed ID: 3315656
[TBL] [Abstract][Full Text] [Related]
13. Mutagenicity studies and D-glucaric acid determination in urine of workers exposed to mineral oils.
Pasquini R; Monarca S; Sforzolini GS; Savino A; Angeli G
Int Arch Occup Environ Health; 1985; 56(4):275-84. PubMed ID: 3905625
[TBL] [Abstract][Full Text] [Related]
14. Can we detect mutagenic activity of urinary sediment by the Ames test?
Bubak A; Mielzyńska D; Siwińska E
Int J Occup Med Environ Health; 1997; 10(1):47-54. PubMed ID: 9187046
[TBL] [Abstract][Full Text] [Related]
15. Biomonitoring of urine mutagenicity with the Ames test: improvement of the extraction/concentration method.
Andre V; Lebailly P; Deslandes E; Henry-Amar M; Gauduchon P
Mutat Res; 2002 Sep; 520(1-2):199-205. PubMed ID: 12297160
[TBL] [Abstract][Full Text] [Related]
16. Mutagenicity monitoring of airborne particulate matter (PM10) in the Czech Republic.
Cerná M; Pastorková A; Vrbíková V; Smíd J; Rössner P
Mutat Res; 1999 Aug; 444(2):373-86. PubMed ID: 10521677
[TBL] [Abstract][Full Text] [Related]
17. Mutagenic activity of overnight urine from healthy non-smoking subjects.
Pavanello S; Lupi S; Pulliero A; Gregorio P; Saia BO; Clonfero E
Environ Mol Mutagen; 2007 Mar; 48(2):143-50. PubMed ID: 17295305
[TBL] [Abstract][Full Text] [Related]
18. Mutagenicity of urine from individuals exposed to LPG combustion products.
Yin XJ; Liu JZ; Kong XH; Chu JH; Wang H; Xiao ZX
Biomed Environ Sci; 1998 Sep; 11(3):251-7. PubMed ID: 9861484
[TBL] [Abstract][Full Text] [Related]
19. Mutagenicity of eight anthracycline derivatives in five strains of Salmonella typhimurium.
Marzin D; Jasmin C; Maral R; Mathe G
Eur J Cancer Clin Oncol; 1983 May; 19(5):641-7. PubMed ID: 6347692
[TBL] [Abstract][Full Text] [Related]
20. Urine mutagenicity of steel workers exposed to coke oven emissions.
De Méo MP; Duménil G; Botta AH; Laget M; Zabaloueff V; Mathias A
Carcinogenesis; 1987 Mar; 8(3):363-7. PubMed ID: 3545525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
